in cardiolog… · biosolve-ii 150 pm magnesium sirolimus tantalum markers 0.27±0.37 (6-m) up to...

1

Upload: others

Post on 01-Jun-2020

0 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: in Cardiolog… · BIOSOLVE-II 150 pm Magnesium Sirolimus Tantalum markers 0.27±0.37 (6-m) Up to I-Y Regulatory approval: EU CE mark / US FDA 6-m: 1.7% MACE Vascular Scaffold/ Abbott

Biosolve syntheses 2010 - Greyhound Chromatography€¦ · Biosolve has developed unique and proprietary routes to demanded molecules useful in R&D or production in industry. Biosolve

Low-Dose Sirolimus Immunoregulation Therapy in Patients ...downloads.hindawi.com/journals/jir/2019/7684352.pdf · Sirolimus, also known as rapamycin, is a macrolide compound that

Prospective, Randomized Evaluation of Sirolimus-Eluting

REVA Medical · native coronary arteries at 24-month follow -up: BIOSOLVE-II and BIOSOLVE -III. TCT 2018. 4) Stone G, et al. Randomized Comparison of Everolimus- and Paclitaxel-Eluting

Verruca Eradication Following Conversion to Sirolimus in a

Long-term clinical data of the BIOSOLVE-II study with the

BIOSOLVE HEADSPACE · range of common residual solvents analysis by GC. Biosolve Headspace grade solvents are suitable dissolution solvents for the analysis of OVI as described by

PROTOCOL STUDY TITLE: Sirolimus in Conjunction …associated with uveitis and diabetic disease. Additionally, the mechanism of action of intravitreal Sirolimus is distinct from that

CardioLog 2011 Administrator Guide · 2016. 10. 6. · SharePoint version. Click Next. CardioLog Configuration Wizard 3. In the Usage Tracking dialog, enter the SharePoint WFE name

nab-Sirolimus for Patients With Malignant Perivascular

Daniel Sedding - jcr.kr · BIOSOLVE-II trial despite more complex lesions being treated in BIOSOLVE-III There was no definite or probable scaffold thrombosis up to 24-month FUP with

Sirolimus-Eluting Balloon with Sustained Releasemedalliance.com/wp-content/uploads/2019/10/19005... · •Sirolimus -a proven safe & effective cytostatic drug •Offering a wider

Biosolve Catalogue 2012-14

MONDAY, SEPTEMBER 24, 2018 - CRF · BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude _PM Roundtable Discussion With Audience QA 2:45 _PM TCT 64: Two Year Clinical and Imaging

sirolimus in hyperinsulnisim Journal club

Sirolimus - Findacure · Sirolimus –a lifeline Dr Hussain and HI team suggested Scarlett start sirolimus on the basis that there is no harm trying at this stage. Scarlett fed well

CardioLog Lite Advanced Administration · CardioLog Lite operates in a non-invasive transparent manner and does not affect the monitored portal„s overall performance and response

Comparison of Vascular Response After Sirolimus-Eluting ...imaging.onlinejacc.org/content/jimg/1/4/475.full.pdf · Sirolimus-Eluting Stent Implantation Between Patients With Unstable

FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

Research Article Conversion to Sirolimus Ameliorates …downloads.hindawi.com › journals › bmri › 2014 › 576929.pdf · Conversion to Sirolimus Ameliorates Cyclosporine-Induced

Sirolimus-eluting Stents: Present and Future

ATTUALITA’ IN TEMA DI STENT BIORIASSORBIBILI? · BIOSOLVE-I n=46 BIOSOLVE-II n=123 BIOSOLVE-III n=63 12 month 36 month 12 month 6 month TLF[%] 23.8 6.8 3.4 3.3 Scaffold Thrombosi

Cardiolog Analytics for Sharepoint Intranet Portals - from Intlock and Atidan

Biosolve Digital Brochure - Home | The BioSolve® Company

Biosolve E - freshbydesign.com.au

Safety and Efficacy of Biosolve CurcuminTM in Active

Biosolve PLUS TM US letter V15 SPREADs QC

Benefits of Interventional Cardiolog Treatments at Best Heart Hospital in India

Biosolve digital brochure 2014 pb

Sirolimus Liposomal Formulations for Targeting of …gala.gre.ac.uk/13326/1/Ichioma_Onyesom_2014.pdf · Sirolimus Liposomal Formulations for Targeting of Cancer Tumours By ... cytoplasmic

MONDAY, SEPTEMBER 24, 2018app.ccheart.com.cn/data/file/20180921/1537513208599084.pdf · BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude _PM Roundtable Discussion With Audience

Case Report Drug Interaction between Sirolimus and ...downloads.hindawi.com/journals/crit/2014/548243.pdf · Case Report Drug Interaction between Sirolimus and Ranolazine in a Kidney

Tank Cleaning with BioSolve

Multicenter International LAM Efficacy of Sirolimus (MILES) Trial

Randomized Comparison between Sirolimus (Cypher)/Sirolimus-analogous (Xience; Promus) vs. Paclitaxel (Taxus vs.Costar) Eluting Stents in Coronary Lesions: